Prostate Restored
Prostate Restored
Photo: Lukas
Lactobacillus paracasei can help prevent symptom recurrence and improve the quality of life in patients with chronic bacterial prostatitis therefore reducing antibiotic use, according to a new study.
Medical treatment, regular exercise, and dietary changes can be used to keep atherosclerosis from getting worse and stabilize the plaque, but they...
Read More »
Blood Tests A low level of red blood cells, white blood cells or platelets may indicate that the lymphoma is present in the bone marrow and/or blood.
Read More »
Fluxactive Complete is conveniently packed with over 14 essential prostate powerhouse herbs, vitamins and grade A nutrients which work synergistically to help you support a healthy prostate faster
Learn More »Chronic bacterial prostatitis (CBP) is a rare condition that causes recurring infections in the prostate and results in swelling, inflammation, and frequent urinary tract infections (UTIs). Previous research has suggested that probiotics, in particular Lacobacillus strains, could modulate the infammatory pathway regulating the bowel infammatory status, suggesting a role in prostatic diseases, too. What's more, Vicari et al., documented that probiotics play a role in the management of patients affected by CBP and irritable bowel syndrome. But no previous study has addressed the therapeutic role of Lactobacilli in the management of CBP while evaluating its role in the decrease of antibiotic use. Therefore the purpose of the current research was to evaluate the efficacy of Lactobacillus paracasei CNCM I-1572 (L. casei DG by SOFAR) in both prevention of symptomatic recurrences and improvement of quality of life in 84 patients with CBP. All patients were treated with antibiotics in agreement with EAU guidelines and then were treated with L. casei DG (2 capsules/day for 3 months). Clinical and microbiological analyses were carried out before and 6 months after the treatment. Analysis included NIH Chronic Prostatitis Symptom Index (CPSI), International Prostate Symptom Score (IPSS) and Quality of Well-Being (QoL) questionnaires. Results suggest that the supplement reduced both the symptomatic recurrence and the use of antibiotics. Tommaso Cai, the principal investigator, explains that the treatment of patients with CBP is currently based on the administration of antibiotics for long periods - about 4 or 6 weeks - and that may be the reason for intestinal bacterial flora modifications and development of bacterial resistances. "Moreover, the imbalance in bowel microbiota could be the reason for recurrence and antimicrobial resistance. For this reasons, an antibiotic-sparing approach is urgently required for managing this kind of patients. "Here, we focused our attention on the need for an antimicrobial-sparing approach in line with the principles of antimicrobial stewardship. "This is significant as The World Health Organization reports that the antibiotic resistance is one of the biggest threats to global health, food security, and development today - it leads to longer hospital stays, higher medical costs and increased mortality."
There is no guarantee that zinc will help you feel better faster. In some studies, zinc did nothing to shorten how long people with colds felt bad....
Read More »
Besides cancer, other conditions that can raise PSA levels include an enlarged prostate (also known as benign prostatic hyperplasia or BPH ) and an...
Read More »After 6 months, 61 patients (72.6%) reported a clinical improvement of symptoms with a return to their pre-symptom status. A time dependent improvement in clinical symptoms with significant changes in NIH-CPSI, IPSS and QoL, was also reported. The team recorded that L. casei DG treatment induced a statistically significant decrease in both symptomatic recurrence (1.9/3 months vs 0.5/3 months) and antibiotic use (− 7938 UDD). The report concludes: "Our results suggest that L. casei DG reduces both the symptomatic recurrence and the use of antibiotics. Therefore, the use of L. casei DG after antibiotic treatment represents a valid tool to improve the antibiotic stewardship in urological setting. "In an economic perspective, our findings suggest a reduction in direct costs related to the reduction of antibiotic daily dose and indirect costs related to the patients’ well-being (less lost working days, less stress and anxiety), even if we did not re-evaluate this economic outcome." Andrea Biffi, Chief Executive Officer of SOFAR S.p.A. told NutraIngredients: “This study demonstrated the efficacy of our strain L. casei DG in proctology, allowing SOFAR, one of the leading companies in the Microbiome research, to open a completely new and of huge interest research field for probiotics” The researchers point out that the lack of control group and the possible placebo effect could be considered limitations of the study. They say larger clinical trials with a randomised and blinded design are needed to confrm these results especially in terms of economic perspectives.
Ask your doctor if you have any questions. Take the capsule approximately 30 minutes after the same meal each day. Swallow the capsule whole. Nov...
Read More »
The tradition of women changing their last names to match their husbands' has its origins in the property transfer that took place upon marriage,...
Read More »
The TURP procedure takes about 60 to 90 minutes to perform. Before surgery you'll be given either general anesthesia — which means you'll be...
Read More »
Techniques that may help people get a flat stomach include: Add cardio. Share on Pinterest Running is effective in trimming a person's midsection....
Read More »
Promotion
Promotion
Promotion